BlackRock Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $111K | Sell |
25,806
-2,162
| -8% | -$9.3K | ﹤0.01% | 2925 |
|
|
2016
Q3 | $275K | Sell |
27,968
-6,619
| -19% | -$65.1K | ﹤0.01% | 2451 |
|
|
2016
Q2 | $196K | Sell |
34,587
-5,693
| -14% | -$32.3K | ﹤0.01% | 2573 |
|
|
2016
Q1 | $307K | Hold |
40,280
| – | – | ﹤0.01% | 2288 |
|
|
2015
Q4 | $537K | Sell |
40,280
-4,883
| -11% | -$65.1K | ﹤0.01% | 2014 |
|
|
2015
Q3 | $742K | Sell |
45,163
-4,016
| -8% | -$66K | ﹤0.01% | 1885 |
|
|
2015
Q2 | $1.1M | Buy |
49,179
+6,223
| +14% | +$140K | ﹤0.01% | 1555 |
|
|
2015
Q1 | $420K | Buy |
42,956
+34,695
| +420% | +$339K | ﹤0.01% | 2179 |
|
|
2014
Q4 | $94K | Hold |
8,261
| – | – | ﹤0.01% | 3044 |
|
|
2014
Q3 | $95K | Buy |
8,261
+311
| +4% | +$3.58K | ﹤0.01% | 3002 |
|
|
2014
Q2 | $155K | Buy |
7,950
+5,355
| +206% | +$104K | ﹤0.01% | 2763 |
|
|
2014
Q1 | $47K | Hold |
2,595
| – | – | ﹤0.01% | 3246 |
|
|
2013
Q4 | $27K | Buy |
2,595
+797
| +44% | +$8.29K | ﹤0.01% | 3320 |
|
|
2013
Q3 | $22K | Hold |
1,798
| – | – | ﹤0.01% | 3293 |
|
|
2013
Q2 | $17K | Buy |
+1,798
| New | +$17K | ﹤0.01% | 3299 |
|